Team Profile

Michael W. Schuster, MD

Registry Medical Director

Dr. Michael Schuster is Gift of Life's Medical Director, as well as the Director of the Hematopoietic Stem Cell Transplantation Program and Hematologic Malignancy Program of Stony Brook University Hospital in New York. Throughout this career, Dr. Schuster has facilitated more than a thousand stem cell transplants.
Dr. Schuster's research interests include new drug development in hematologic malignancies including multiple myeloma, lymphoma, myelodysplastic syndrome and leukemia; therapeutic uses of cytokines; bone marrow and blood stem cell transplantation; and the role of pro-inflammatory cytokines in geriatric and cancer cachexia, anemia, and in other disease states. He also maintains research interests in the treatment of the immunocompromised host. He is well published in these areas and lectures frequently about topics such as new drug development, transplantation and treatment of hematologic malignancies. For the past seven years, he has been named as one of the Best Doctors in New York.
Serving as the principal investigator for more than 200 clinical trials during the past 20 years, Dr. Schuster has worked extensively in the area of new drug development in oncology and stem cell transplantation. He has been involved in clinical trials that have led to the registration of breakthrough oncology drugs such as Gleevec and Velcade.
Dr. Schuster received his medical degree at Dartmouth Medical School in Hanover, New Hampshire. He completed his training in hematology/oncology at Harvard Medical School's Beth Israel Hospital in Boston, Massachusetts, and his postdoctoral fellowship in molecular biology at Harvard University.

Back to All Team

  • Board of Directors

    The Board is responsible for setting and regularly reviewing the organization’s mission and vision while also ensuring proper governance and managerial oversight.

    read more
  • Medical Advisory Committee

    The Committee provides advice and sets policy on matters and responsibilities as they relate to the continued quality of operations and to the safety of both donors and patients.

    read more
What’s new

Monthly newsletter keeping our supporters in the know